Briefing position
An Angola public offer prospectus review assesses the issuer, instrument, offer terms, use of proceeds, risk factors, financials, governance, valuation, liquidity, tax, currency, CMC disclosures, BODIVA context and unresolved diligence questions. It does not recommend whether to invest.
For committee-facing use, pair this research with Angola Institutional Source Verification and Contact OHUASI before turning source analysis into a decision memo.
The short answer
An Angola public offer prospectus review assesses the issuer, instrument, offer terms, use of proceeds, risk factors, financials, governance, valuation, liquidity, tax, currency, CMC disclosures, BODIVA market context and unresolved diligence questions. The output is a decision-support memo, not a recommendation to invest.
Who this is for
This review is for investors and advisers evaluating public offers, listed or market-admitted securities, privatization-linked transactions, bond offerings, equity offerings or securities distributed through Angola’s capital market infrastructure.
It is designed for:
- Investment committees.
- Family offices.
- Corporate treasury teams.
- Institutional investors.
- Strategic buyers.
- Advisors preparing client memoranda.
- Foreign investors seeking a structured source pack.
What the review covers
Source pack verification
We map the prospectus, launch announcement, supplements, issuer reports, CMC materials, BODIVA context, intermediary instructions and other source documents. Each source is tagged by what it proves and what it does not prove.
Issuer analysis
We review business model, ownership, financial condition, governance, sector exposure, related-party risks, regulation and dependence on public counterparties.
Instrument terms
We identify whether the instrument is equity, bond, preferred instrument, fund unit or other security. The review maps rights, ranking, coupon or dividend policy, maturity, conversion, redemption, voting rights and restrictions.
Offer economics
We assess offer size, price, valuation basis, use of proceeds, seller versus issuer proceeds, allocation, subscription period, settlement and eligibility.
Risk factors
We translate the prospectus risk section into committee language. The goal is not to copy risk factors, but to rank them, connect them to evidence and show residual exposure.
Liquidity and exit
We review expected free float, market depth, BODIVA context, investor base, trading assumptions and realistic exit paths. Listing or admission does not guarantee liquidity.
Currency, tax and settlement
We identify issues that require tax, legal or intermediary confirmation: subscription currency, income currency, withholding, custody, repatriation, KYC and settlement process.
What you receive
Prospectus review memo
A structured memo summarizing issuer, instrument, offer terms, risk factors, valuation issues and unresolved questions.
Source pack log
A dated list of documents reviewed, including official sources and their decision relevance.
Risk matrix
A table ranking risks by severity, evidence, mitigation and residual exposure.
Committee decision template
A memo framework that can support subscribe, subscribe with limits, monitor, decline or escalate decisions.
What this is not
This is not:
- Investment advice.
- Legal advice.
- Tax advice.
- Brokerage.
- Underwriting.
- A recommendation to buy or sell.
- A guarantee that an offer is safe.
- A substitute for regulated advice or intermediary obligations.
Review process
Step 1: source intake
You provide the prospectus, announcement, supplements, issuer documents and any intermediary instructions.
Step 2: source verification
We check whether the document chain is complete and identify missing or outdated materials.
Step 3: memo construction
We build the investor memo around issuer, instrument, price, risk, liquidity, tax/currency and decision logic.
Step 4: open-question list
We identify questions to ask the issuer, intermediary, tax adviser, legal adviser or custodian.
Step 5: final review pack
You receive the memo, source log, risk matrix and committee-ready questions.
Intake questions
- What offer is being reviewed?
- What security type is involved?
- Are you a local or foreign investor?
- What documents are available?
- What is the intended investment size?
- Is the decision for committee, board, client or internal screening?
- Are tax and legal advisers already involved?
- What is the deadline?
FAQ
Does prospectus review mean the offer is approved for investment?
No. The review helps understand documents and risks. It does not approve or recommend investment.
Can you review Portuguese documents?
Yes. The corpus is designed around English and Portuguese Angola capital-market materials.
Is CMC disclosure enough to invest?
No. CMC disclosure helps verify official materials, but investment judgment requires financial, risk, liquidity, legal and tax analysis.
Why focus on liquidity?
Because a security can be public or admitted and still be difficult to exit. Liquidity affects position size and required return.
Primary source anchors
Use these controlled entry points when the research moves from reading into committee review, source verification, or transaction screening.